RHS Financial LLC lifted its holdings in Plexus Corp. (NASDAQ:PLXS – Free Report) by 61.9% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 2,591 shares of the technology company’s stock after purchasing an additional 991 shares during the period. RHS Financial LLC’s holdings in Plexus were worth $351,000 at the end of the most recent quarter.
Several other hedge funds have also recently modified their holdings of the business. CWM LLC lifted its position in shares of Plexus by 65.7% in the 2nd quarter. CWM LLC now owns 537 shares of the technology company’s stock worth $73,000 after purchasing an additional 213 shares during the period. Vanguard Personalized Indexing Management LLC lifted its position in shares of Plexus by 11.8% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 3,610 shares of the technology company’s stock worth $488,000 after purchasing an additional 381 shares during the period. Inspire Investing LLC lifted its position in shares of Plexus by 7.4% in the 2nd quarter. Inspire Investing LLC now owns 2,881 shares of the technology company’s stock worth $390,000 after purchasing an additional 199 shares during the period. Blue Trust Inc. lifted its position in shares of Plexus by 26.8% in the 2nd quarter. Blue Trust Inc. now owns 1,073 shares of the technology company’s stock worth $145,000 after purchasing an additional 227 shares during the period. Finally, 111 Capital purchased a new stake in shares of Plexus in the 2nd quarter worth approximately $340,000. Hedge funds and other institutional investors own 94.45% of the company’s stock.
Analysts Set New Price Targets
A number of equities research analysts recently commented on the stock. Williams Trading set a $165.00 target price on shares of Plexus in a research report on Monday, September 22nd. Needham & Company LLC decreased their target price on shares of Plexus from $162.00 to $158.00 and set a “buy” rating for the company in a research report on Thursday, July 24th. Sidoti raised shares of Plexus from a “neutral” rating to a “buy” rating and increased their target price for the company from $135.00 to $150.00 in a research report on Friday, July 25th. Stifel Nicolaus set a $140.00 target price on shares of Plexus in a research report on Thursday, July 24th. Finally, Wall Street Zen raised shares of Plexus from a “buy” rating to a “strong-buy” rating in a research report on Saturday. Three research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, Plexus presently has an average rating of “Moderate Buy” and a consensus price target of $155.60.
Insider Transactions at Plexus
In other news, CEO Todd P. Kelsey sold 1,500 shares of the stock in a transaction on Wednesday, October 1st. The shares were sold at an average price of $143.70, for a total value of $215,550.00. Following the sale, the chief executive officer owned 69,214 shares in the company, valued at $9,946,051.80. This represents a 2.12% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Patrick John Jermain sold 2,500 shares of the stock in a transaction on Wednesday, August 27th. The stock was sold at an average price of $137.71, for a total transaction of $344,275.00. Following the completion of the sale, the chief financial officer owned 20,959 shares in the company, valued at $2,886,263.89. The trade was a 10.66% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 15,856 shares of company stock valued at $2,142,440. 1.76% of the stock is owned by corporate insiders.
Plexus Trading Down 9.2%
NASDAQ PLXS opened at $133.69 on Monday. The company has a fifty day simple moving average of $137.81 and a two-hundred day simple moving average of $132.20. The stock has a market cap of $3.61 billion, a P/E ratio of 22.78 and a beta of 0.80. Plexus Corp. has a 12-month low of $103.43 and a 12-month high of $172.89. The company has a current ratio of 1.58, a quick ratio of 0.74 and a debt-to-equity ratio of 0.06.
Plexus (NASDAQ:PLXS – Get Free Report) last posted its quarterly earnings results on Wednesday, July 23rd. The technology company reported $1.90 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.71 by $0.19. The business had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.02 billion. Plexus had a net margin of 4.04% and a return on equity of 12.33%. The business’s quarterly revenue was up 6.0% on a year-over-year basis. During the same quarter last year, the company posted $1.45 earnings per share. Plexus has set its Q4 2025 guidance at 1.820-1.970 EPS. On average, analysts forecast that Plexus Corp. will post 5.9 earnings per share for the current year.
About Plexus
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Read More
- Five stocks we like better than Plexus
- What is the NASDAQ Stock Exchange?
- Microsoft 365 Premium Marks the Next Phase of AI Monetization
- Best Aerospace Stocks Investing
- Could Target’s Week of Discounts Come Full Circle for Investors?
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- 3 Reasons to Buy Sprouts Farmers Market Ahead of Earnings
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.